(Q81463912)
Statements
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma (English)
John P Leonard
Christos Emmanouilides
Stephanie A Gregory
Daniel Weisdorf
Jeffrey Andrey
John Hainsworth
Joseph A Sparano
Donald E Tsai
Sandra Horning